2. Infection

Infection

Infection

Related Products

PDF 70.44 MB

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N14482
    Phenelfamycins D 118498-94-5 98%
    Phenelfamycins D is an antibiotic. Phenelfamycins D can be found in Streptomyces violaceoniger AB 9991-80 and Streptomyces violaceoniger AB 1047T-33, each component of which has anti-eutrophic bacterial activity.
    Phenelfamycins D
  • HY-N14483
    Phenelfamycins C 118498-93-4 98%
    Phenelfamycins C is an antibiotic. Phenelfamycins C can be found in Streptomyces violaceoniger AB 9991-80 and Streptomyces violaceoniger AB 1047T-33, each component of which has anti-eutrophic bacterial activity.
    Phenelfamycins C
  • HY-N14484
    Kigamicin D 680571-52-2 98%
    Kigamicin D shows activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) with MICs of 0.025-0.78 μg/mL. Kigamicin D also shows effect against L-1210 LB32T and other genera tumor cells with IC50 of 1 μg/mL.
    Kigamicin D
  • HY-N14485
    Nebramycin Ⅳ 51736-76-6 98%
    Nebramycin IV is an aminoglycoside antibiotic. Nebramycin IV has a broad antibacterial spectrum and has a strong effect on Gram-positive and negative bacteria and mycobacteria.
    Nebramycin Ⅳ
  • HY-N14486
    Neihumicin 111451-12-8 98%
    Neihumicin is resistant to beer Saccharomyces yeast ATCC 9763 and Penicillium italium Wehmer, but not to bacteria.
    Neihumicin
  • HY-N14487
    Nemotin 502-12-5 98%
    Nemotin has the activity against Gram-positive bacteria, mycobacterium and fungus, and also against Gram-negative bacteria, but the activity is weak.
    Nemotin
  • HY-N14488
    Nemotinic acid 539-98-0 98%
    Nemotinic acid has the activity against Gram-positive bacteria, mycobacterium and fungus, and also against Gram-negative bacteria, but the activity is weak.
    Nemotinic acid
  • HY-N14489
    Neocopiamycin A 89989-28-6 98%
    Neocopiamycin A is broad-spectrum resistant to Gram-positive bacteria, yeast and filamentous fungi.
    Neocopiamycin A
  • HY-N1448R
    Vincetoxicoside B (Standard) 22007-72-3
    Vincetoxicoside B (Standard) is the analytical standard of Vincetoxicoside B. This product is intended for research and analytical applications. Vincetoxicoside B shows antifungal activity.
    Vincetoxicoside B (Standard)
  • HY-N14490
    Coumamidine γ1 121634-35-3 98%
    Coumamidine γ1 is a kind of alkaline sugar Cinodine antibiotic, which has broad spectrum antibacterial activity and also has effect on pseudomonas aeruginosa.
    Coumamidine γ1
  • HY-N14491
    Coumamidine γ2 121634-34-2 98%
    Coumamidine γ2 is a kind of alkaline sugar Cinodine antibiotic, which has broad spectrum antibacterial activity and also has effect on pseudomonas aeruginosa.
    Coumamidine γ2
  • HY-N14492
    Coumermycin A2 3130-60-7 98%
    Coumermycin A2 has anti-Gram positive bacteria, negative bacteria, mycobacterium (weak) activity.
    Coumermycin A2
  • HY-N14494
    Neoviridogrisein Ⅰ 66002-39-9 98%
    Neoviridogrisein I has been used to resist Gram-positive bacteria and mycoplasma.
    Neoviridogrisein Ⅰ
  • HY-N14496
    Nisamycin 150829-93-9 98%
    Nisamycin has stronger anti-Gram-positive bacteria and weaker anti-fungal and individual Gram-negative bacteria activities. Nisamycin has weak cytotoxic effect. The IC50 of mouse leukemia P388 cells is 4.8 μg/mL.
    Nisamycin
  • HY-N14497
    Nocardicyclin A 199173-81-4 98%
    Nocardicyclin A is resistant to Gram-positive bacteria, mycobacterium and Nocardia.
    Nocardicyclin A
  • HY-N14499
    Saframycin H 92569-01-2 98%
    Saframycin H has the effect of anti-Gram-positive bacteria. Saframycin H has the effect of inhibiting mouse lymphocyte L-1210 with an ID50 of 0.033 μM.
    Saframycin H
  • HY-N14501
    Mycinamicin Ⅲ 73684-70-5 98%
    Monamycin III is an ester peptide antibiotic. Monamycin III has activity against Gram-positive bacteria.
    Mycinamicin Ⅲ
  • HY-N14503
    Mycinamicin Ⅳ 73684-71-6 98%
    Monamycin IV is an ester peptide antibiotic. Monamycin IV has activity against Gram-positive bacteria.
    Mycinamicin Ⅳ
  • HY-N14504
    Mycinamicin V 73684-72-7 98%
    Monamycin V is an ester peptide antibiotic. Monamycin V has activity against Gram-positive bacteria.
    Mycinamicin V
  • HY-N14505
    Mycinamicin Ⅵ 85687-36-1 98%
    Mycinamicin VI is a macrolide antibiotic. Mycinamicin VI shows activity against Gram-positive bacteria.
    Mycinamicin Ⅵ
Cat. No. Product Name / Synonyms Application Reactivity